Molecular Cyclotrons Private Limited, a active private limited company, was established on 29 June 2011 in Trichur, Kerala, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U52310KL2011PTC028744. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹3.50 Cr and a paid-up capital of ₹3.35 Cr.
Formerly known as Ceevees Medical Radioisotopes Private Limited. It upholds a compliant status. Its leadership includes Mibu Jose (Director), Chirayath Paulson Varkey (Managing Director), Kizhakkebhagathu Ajith Joy (Managing Director). Past directors included Kizhakkebhagathu Ajith Joy. It holds no open charges and ₹11.26 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Viii/843, Ceeveesadan Ancherichira P O, Trichur, Kerala, 680006.
U52310KL2011PTC028744
028744
29 June 2011
₹3.50 Cr
₹3.35 Cr
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Molecular Cyclotrons Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mibu Jose | Director | 01 Sep 2012 | Current |
| Chirayath Paulson Varkey | Managing Director | 29 Jun 2011 | Current |
| Kizhakkebhagathu Ajith Joy | Managing Director | 29 Jun 2011 | Current |
| Methale Purayil Hassan Kunhi | Director | 01 Sep 2012 | Current |
| Mathew Francis Kattukkaran | Director | 01 Sep 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jan 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Molecular Cyclotrons Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.19% increase. The company also saw a substantial improvement in profitability, with a 79.34% increase in profit. The company's net worth dipped by a decrease of 2.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Molecular Cyclotrons's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹112,563,250.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2021 | The Catholic Syrian Bank Ltd | ₹4.40 M | Satisfied |
| 28 Sep 2021 | The Catholic Syrian Bank Ltd | ₹1.00 Cr | Satisfied |
| 30 Sep 2014 | Others | ₹2.19 Cr | Satisfied |
| 01 Jul 2014 | Others | ₹7.63 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Molecular Cyclotrons, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Molecular Cyclotrons, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Molecular Cyclotrons's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Molecular Cyclotrons Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge registered on 28 Sep 2021 via Charge ID 100482749 with The Catholic Syrian Bank Ltd was fully satisfied on 22 May 2024. was documented.
Molecular Cyclotrons Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was recorded as a recent event.
A charge registered on 01 Jul 2014 via Charge ID 10539647 with Others was fully satisfied on 09 Feb 2023. was recorded as a recent event.
A charge registered on 28 Sep 2021 via Charge ID 100493415 with The Catholic Syrian Bank Ltd was fully satisfied on 26 May 2022. was recorded as a recent event.
Progress on A charge with The Catholic Syrian Bank Ltd amounted to Rs. 0.44 Cr with Charge ID 100493415 was registered on 28 Sep 2021. was documented.
The CIN of Molecular Cyclotrons Private Limited is U52310KL2011PTC028744.
Molecular Cyclotrons Private Limited is headquartered at Viii/843, Ceeveesadan Ancherichira P O, Trichur, Kerala, 680006.
Molecular Cyclotrons Private Limited was incorporated on 29 June 2011.
The current directors of Molecular Cyclotrons Private Limited are
The primary industry of Molecular Cyclotrons Private Limited is Hospital And Medical Care.
Molecular Cyclotrons Private Limited is unlisted.
The authorized capital of Molecular Cyclotrons Private Limited is ₹3.50 Cr, and the paid-up capital is ₹3.35 Cr.
The compliance status of Molecular Cyclotrons Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX